T1	Participants 305 328	colorectal cancer (CRC)
T2	Participants 367 461	asymptomatic patients who are 50-79years and are not up-to-date with CRC screening guidelines.
T3	Participants 536 558	GERA or Control group.
T4	Participants 841 893	Of 2,223 eligible patients, 562 (25%) have enrolled.
T5	Participants 894 989	Patients who enrolled in the study were significantly younger than those who did not (p<0.001).
T6	Participants 990 1125	Participants tended to be 50-59years (64%), female (58%), white (52%), married (51%), and have more than a high school education (67%).
T7	Participants 1347 1412	One in four eligible primary care patients enrolled in the study.
